Gilead Sciences (GILD) saw significant selling pressure on Friday after the company reported its second quarter earnings. Shares gapped open lower and then lacked direction in the first hour before easing throughout the rest of the session.
The stock broke support and slipped below its 50-day moving average. Shares closed at their lowest level since mid-April, down $5.87 at $49.53.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.